P-16(13therapeutics)

N/A

Report date: 2025/01/26 15:41:09

Base Information

Drug NameP-16(13therapeutics)
Drug Alias NameP-17(13therapeutics)P-18(13therapeutics)toll-like receptor inhibitors (13Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionToll like receptor 4 inhibitorsToll like receptor 9 antagonists
TargetsToll like receptor 4Toll like receptor 9
Therapy Area/IndicationsInflammationAutoimmune DiseasesAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies13Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies13Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A